Department of Microbiology, Ahmadu Bello University, Zaria, Nigeria.
J Infect Dis. 2010 Sep 1;202 Suppl:S198-204. doi: 10.1086/653570.
Nigeria has recently been ranked third among the 10 countries with the greatest number of rotavirus disease-associated deaths per year. Estimates attribute up to 33,000 deaths annually to rotavirus disease in Nigerian children <5 years old. Although the introduction of the new oral, live attenuated rotavirus vaccines may not occur for another 4-6 years in developing countries, background data on burden of disease, cost of rotavirus disease, and characterization of circulating strains is required to hasten this introduction to children who would clearly benefit from the intervention.
Between July 2002 and July 2004, fecal specimens were collected from 869 infants and young children <5 years of age presenting with diarrhea in Kaduna, Kebbi, Sokoto, and Zamfara states in northwestern Nigeria. In addition, 194 control specimens were also collected from children matched for age. Specimens were screened for the presence of rotavirus antigens. Rotavirus-positive specimens were further analyzed to determine electropherotype, subgroup specificity, and G and P genotypes.
Rotavirus was detected in 18% of children with diarrhea and 7.2% of the age-matched case control subjects. The highest rotavirus burden was detected in children aged <6 months. The majority of the rotavirus-positive specimens revealed viruses of long electropherotypes, subgroup II specificity, and G1P[8] genotypes. Furthermore, more than a quarter of specimens (37%) displayed mixed G and P genotypes, and almost a third could not be genotyped.
The high numbers of mixed rotavirus infections highlight the multitude of enteric pathogens to which children in African countries are exposed. Data on circulating rotavirus strains serve to inform African government officials to the serious health threat posed by rotavirus in their respective countries and to document the diversity of strains before vaccine introduction.
尼日利亚最近在每年与轮状病毒疾病相关的死亡人数最多的 10 个国家中排名第三。据估计,每年尼日利亚 5 岁以下儿童因轮状病毒疾病而死亡的人数高达 3.3 万。虽然新的口服、减毒轮状病毒疫苗可能要在发展中国家再等 4 到 6 年才能推出,但为了尽快为那些显然能从干预措施中受益的儿童接种疫苗,需要获得有关疾病负担、轮状病毒疾病成本和循环株特征的背景数据。
2002 年 7 月至 2004 年 7 月,在尼日利亚西北部的卡杜纳、凯比、索科托和赞法拉州采集了 869 名 5 岁以下患有腹泻的婴幼儿粪便标本。此外,还从年龄匹配的对照组儿童中采集了 194 份对照标本。对标本进行轮状病毒抗原检测。对轮状病毒阳性标本进一步分析,以确定电镜图型、亚组特异性和 G 和 P 基因型。
在腹泻儿童中,18%的儿童和年龄匹配的对照组儿童中检测到轮状病毒。轮状病毒负担最高的是<6 个月的儿童。大多数轮状病毒阳性标本显示出长电镜图型、亚组 II 特异性和 G1P[8]基因型的病毒。此外,超过四分之一的标本(37%)显示混合的 G 和 P 基因型,近三分之一的标本无法进行基因分型。
混合轮状病毒感染的高数量突显了非洲国家儿童所面临的多种肠道病原体。循环轮状病毒株的数据有助于告知非洲政府官员轮状病毒在各自国家构成的严重健康威胁,并在疫苗推出之前记录菌株的多样性。